FF Advisors’s AbbVie ABBV Stock Holding History

FF Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$394K	Buy	1,567 +4	+0.3%	+$861	0.15%	87
2026 Q1	$314K	Hold	1,563	–	–	0.13%	97
2025 Q4	$357K	Buy	1,563 +2	+0.1%	+$456	0.16%	81
2025 Q3	$361K	Buy	1,561 +22	+1%	+$4.48K	0.17%	77
2025 Q2	$286K	Buy	1,539 +53	+4%	+$9.85K	0.15%	84
2025 Q1	$280K	Hold	1,486	–	–	0.16%	77
2024 Q4	$258K	Hold	1,486	–	–	0.17%	82
2024 Q3	$291K	Hold	1,486	–	–	0.19%	70
2024 Q2	$255K	Hold	1,486	–	–	0.18%	78
2024 Q1	$271K	Buy	1,486 +86	+6%	+$14.8K	0.19%	74
2023 Q4	$217K	Buy	+1,400	New	+$204K	0.18%	76

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

FF Advisors's ABBV Position: Q2 2026 in Review

FF Advisors increased its AbbVie (ABBV) stake by 0.26% in Q2 2026, buying an estimated $861 and bringing the position to 1,567 shares worth $394K. The position accounts for 0.15% of the portfolio, ranked #87.

FF Advisors first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

FF Advisors held 1,567 shares of AbbVie worth $394K as of Q2 2026.
FF Advisors bought 4 AbbVie shares in Q2 2026, an estimated $861.
AbbVie made up 0.15% of FF Advisors's portfolio in Q2 2026, its #87 holding.
FF Advisors first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on FF Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.